Efficacy and safety of oral vinorelbine (NVBO) in first- or second-line metastatic breast cancer (MBC)

被引：1
|
作者：
Blancas, I.
Morales, S.
Diaz, N.
Barnadas, A.
Gonzalvez, M. L.
del Barco, S.
Lopez de Ceballos, M. H.
Perez, F. J.
Llombart-Cussac, A.
机构：
[1] Hosp Univ Clin San Cecilio, Granada, Spain
[2] Hosp Univ Arnau de Villanova, Lleida, Spain
[3] Hosp Clin San Juan, Alicante, Spain
[4] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[5] Hosp Univ Virgen de la Arrixaca, Murcia, Spain
[6] ICO Hosp Josep Trueta, Girona, Spain
[7] Hosp San Pedro de Alcantara, Caceres, Spain
[8] Inst Catala Oncol, Clin Res Unit, Lhospitalet De Llobregat, Spain
[9] Hosp Arnau Vilanova, Lleida, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.1090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1090
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of weekly oral vinorelbine (NVBO) as single agent in first- or second-line metastatic breast cancer (MBC)
    Morales, Serafin
    Blancas, Isabel
    Luisa Gonzalvez, Maria
    Barnadas, Agust
    Diaz, Nieves
    Servitja, Sonia
    del Barco, Sonia
    Margeli, Mireia
    Garcia Carbonero, Iciar
    Alvarez, Ruth
    Helena Lopez de Ceballos, Maria
    Javier Perez, Francisco
    Llombart Cussac, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Oral vinorelbine (NVBO) in combination with trastuzumab (HER) in metastatic breast cancer (MBC): Data on efficacy and safety when administered in first- or second-line treatment.
    Illarramendi, J. J.
    Blancas, I.
    Bueso, P.
    Carabantes, F.
    Polo Marques, E.
    Ciruelos Gil, E.
    Corral, M.
    Perez, F. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] A Phase I/II study of capecitabine (X) combined with oral vinorelbine IN) as first- or second-line chemotherapy in patients (pts) with locally advanced or metastatic breast cancer (MBC)
    Delcambre, C.
    Veyret, C.
    Levy, C.
    Switsers, O.
    Allouache, D.
    Raban, N.
    Grellard, J. M.
    Leconte, A.
    Delozier, T.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 118 - 118
  • [4] A Phase II randomized trail of lapatinib with either vinorelbine or capecitabine in ErbB2-overexpressing first- and second-line metastatic breast cancer (MBC)
    Janni, W.
    Alvarez, J. V.
    Papadimitriou, C. A.
    Karaszewska, B.
    Wiest, W.
    Lim, M. L.
    Das-Gupta, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] A phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first- and second-line therapy for ErbB2-overexpressing metastatic breast cancer (MBC): Safety results
    Janni, W.
    Sarosiek, T.
    Papadimitriou, C. A.
    Gallego, J. V. Alvarez
    Caruso, M.
    Wiest, W.
    Lim, M. L.
    Andersson, H.
    Das-Gupta, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] A pooled analysis of efficacy and safety of vinorelbine in combination with capecitabine in first-line metastatic breast cancer (MBC)
    Valev, Spartak S.
    Taushanova, Margarita
    Krasteva, Ely
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 163 - 163
  • [7] Docetaxel: Efficacy in first- and second-line therapy of advanced breast cancer
    Crown, J
    [J]. ONKOLOGIE, 2000, 23 : 1 - 3
  • [8] A Phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first- and second-line therapy for ErbB2-overexpressing metastatic breast cancer (MBC)
    Janni, W.
    Sarosiek, T.
    Pikiel, J.
    Karaszewska, B.
    Staroslawska, E.
    Salat, C.
    Caglevic, C.
    Potemski, P.
    Brain, E.
    Briggs, K.
    de Silvio, M.
    Sapunar, F.
    Papadimitriou, C.
    [J]. CANCER RESEARCH, 2012, 72
  • [9] A phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first- and second-line therapy for HER2 overexpressing metastatic breast cancer (MBC).
    Papadimitriou, Christos A.
    Sarosiek, Tomasz
    Pikiel, Joanna
    Karaszewska, Boguslawa
    Salat, Christoph
    Caglevic, Christian
    Potemski, Piotr
    Brain, Etienne
    Briggs, Kathryn Jane
    DeSilvio, Michelle
    Marini, Luca
    Janni, Wolfgang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
12345